Physiotherapy management for Bronchial Asthma
A. IN EARLY STAGES –
Bronchial asthma is a disease of the upper
respiratory tract, our upper respiratory tract produce symptoms lsuch as shortness of
breath in midnight wheez and cough periodically with change the environment.
It is termed as a reversible condition of upper
respiratory tract of bronchus associated
with inflammation of airway, reversible changes in smooth muscle of bronchioles
with hyper-responsiveness.
Due to inflammation of the mucosa, spasm of bronchial
smooth muscle and over production of mucus reduce the diameter of upper
respiratory tract with occlusion and narrowing.
- Intrinsic
- Extrinsic
- Mixed
Features
|
Intrinsic
|
Extrinsic
|
Age
|
In
adult
|
In
child hood
|
Personal/Family
history
|
Absent
|
Commonly
present
|
Preceding
allergic illness
|
Absent
|
Present
|
Allergens
|
None
|
present
|
Drug
hypersensitivity
|
Present
(usually aspirin)
|
None
|
Serum
IgG levels
|
Normal
|
Elevated
|
Associated
chronic bronchitis, nasal Polyps
|
Present
|
Absent
|
Emphysema
|
Common
|
Unusual
|
It is included in chronic obstructive disease because
it produce COPD like symptoms.
According to National Center for Health Statics and Center
for Disease Control and Prevention it
is in United States has increased from 7.3% to 8.4% in 2010. About 1 in 11
children and 1 in 12 adults suffered from asthmatic conditions. It is
approximate 27.7 million people in United States suffered from this condition. According to WHO about 235 million people worldwide
suffering from asthma.
Frequency
|
sever controlled
|
Sever
uncontrolled
|
More
then once a day
|
18%
|
55%
|
once
a day
|
8%
|
15%
|
More
than 2 times per week, but not daily
|
27%
|
22%
|
2
or less times per week, but not daily
|
36%
|
8%
|
Rarely
|
11%
|
0%
|
Environmental Factor
•
Allergies from –
fumes, cold air, dust and other product.
•
Upper
respiratory tract infection with Bacteria, virus and fungal infection).
•
Smoking and
tobacco chewing.
•
Occupational
pollutants-eg. Sugar cane factory workers, formers.
•
Drugs (NASAID,
Aspirin and B-Blockers).
•
Asthma attack
during exercise (exercise induce asthma).
•
Asthma attack
during Anxiety or in Emotional condition.
•
Idiopathic or
related with autoimmune condition.
Host Factor
•
Genetically
inherited asthma attack
•
Asthma attack produce during obesity
•
Sex
or Gender
It is 2 times more common
in boys before 14 years and in adults it is more common in women.
Following
changes occurs in upper respiratory tract in asthma
- Respiratory tract is hyper responsive may produces inflammation and increase production of mucus in excess amount within the airway. It may be normal or degenerated.
- Inflammation and hyper responsive of airway and increase amount of mucus production produced by some infections or allergens within the respiratory tract.
- Increase thickening of bronchial basement membrane because changes of epithelium and form twist strips due to collection of eosinophils in sputum.
- After collection of lymphocytes, eosinophils and plasma cells it may produce hypertrophy of submucosal glands and submucosal edema.
It is an obstructive pathology may produce following
sing and symptoms
- Shortness of breath in midnight
- Feeling of anxiety
- Cyanosis may be present because of hypoxia due to lack of oxygen
- Cold extremity
- Usually
wheez Crepitus/Crackles type
of abnormal sounds are present
- Cough is more common sign in asthma patients
- Patient not able to speak full sentence
- Pulsus paradox changes in breathing pattern in severe cases
- Barrel shape chest deformity because increase anterior posterior diameter
- Present tripod sign in sever cases
- Hyper resonant percussion note are present
- Decrease tactile vocal fremitus with diminish breath sound
- I: E ratio it will be changed >1:3
Global initiative for asthma (GINA) provides general guideline to help in the clinical
diagnosis of asthma, which are based on patient’s symptoms and medical history.
These are includes wheezing and history of following-
- Recurrent tightness of chest in patients
- Recurrent difficult of breathing in patients
- Recurrent cough in patients
- Recurrent wheez type of abnormal sound
Following
tests are used to diagnose the asthma attack
Pulmonary Function Test
This test measure the variability of airflow
limitation, severity, reversibility
Following findings suggest it may be asthma
- FEV1 =increase FEV1 of 12% (<200ml) after bronchodilator use suggest asthma attack
- FEV1/FVC ratio = < 0.75 to 0.85
- PEFR =60 L/m > =10-20%
Moderate To Severe Asthmatic Episode
(Obstructive Lung Pathology)
Forced Expiratory Volume and Flow Rate Findings
FVC FEV1 FEV1/FV Ratio FEF25%-75%
↓ ↓ ↓ ↓
FEF50% FEF200-1200 PEFR MVV
↓
↓ ↓ ↓
Lung Volume and lung Capacity Findings
IRV ERV VT RV
↓or Normal ↓ or Normal ↑or Normal ↑
VC IC FRC TLC RV/TLC Ratio
↓ ↓or Normal ↑
↑ or Normal ↑or Normal
Note-FVC-forced vital capacity, FEV1-force expiratory
volume in one second, FEV1/FVC ratio-Ratio of FVC and FEV1, FEF-force
expiratory flow 25%-75%, PEFR-peak expiratory flow rate, MVV-maximum voluntary
ventilation, VT-Tidal volume, IRV-inspiratory reserve volume, ERV- expiratory
reserve volume, Residual volume,VC-vital capacity, IC-inspiratory capacity,
FRC-functional residual capacity, TLC-total lung capacity.
Mild to Moderate Asthmatic Episode
Acute Alveolar Hyperventilation with Hypoxemia
(Acute Respiratory
Alkalosis)
pH PaCO2 HCO3 − PaO2 SaO2 or SpO2
↑ ↓ ↓
Normal
↓ ↓
Severe Asthmatic Episode (Status Asthmatics)
Acute Ventilatory Failure with Hypoxemia
(Acute Respiratory Acidosis)
pH PaCO2 HCO3 − PaO2 SaO2
or SpO2
↓ ↑
↑
↓ ↓
Other
diagnostic test
Measure PEFR with peak flow meter
(during asthmatic episode)
- Shape chest-increase anterior/posterior diameter
- Translucent lung field (dark)
- Depressed or flattened diaphragm.
- COPD
- Tropical eosinophilia
- Obstruction of upper respiratory tract
- Allergic lung disease other than asthma
- Medical
- Surgical
- Physiotherapy
Medical
management-
National asthma education and prevention plan (NAEPP)
and
(GINA) Global initiative for asthma provide evidence based guideline for asthma management.
- Attain and maintain control of clinical
manifestations associated with asthma.
- Maintain normal activity level, including exercise'
- Normalize or maintain respiratory functions as possible
- Prevent asthma exarvation
- Avoid adverse effects from asthma
medication
- Prevent asthma mortality
Component 1: Develop
patients/doctor partnership
Component 2: Reduce and identify
exposure to risk factors
Component 3: Assess,
treat and monitor asthma
Component 4: Manage
asthma exacerbation
Component 5: Special
considerations eg. Pregnancy, obesity, surgery and others.
- Mechanical ventilation noninvasive or invasive (if required)
- Oxygen therapy protocol (if needed)
- Nebulization therapy protocal
- Following Drugs are used to maintain patients
- LABAs (long acting Beta2 agents)
- Inhaled corticosteroids
- Combination of Beta2 agents and corticosteroids
- Leukotriene inhibitors
- Xanthine derivatives
- SABAs (short acting Beta2 agents
- Ultra-short acting bronchodilators
Bronchial thermosplasty
Goals for physiotherapy management-
- Prevent intubation
- Prevent mechanical ventilation invasive or noninvasive both
- Reduce dyspnea
- Facilitation mucociliary transport
- Optimize secretion transport
- Optimize alveolar ventilation
- Decrease work of breathing
- Normalize respiratory rate
- Decrease work of heart
- Increase endurance, strength and power of respiratory muscles
- Maximize aerobic capacity and oxygen transport
- Increase lung volume and lung capacity
- Optimize general muscle strength, endurance and power and oxygen level
- Design comprehensive lifelong rehabilitation protocol with patients
Physiotherapy management in patient phase
A. IN EARLY STAGES –
1.
Patient education program
-Education
about disease prevention and control,
-Explain
about effect of smoking and weight reduction,
-Explain
about dyspnea reliving position during sudden asthma attack
-Upper
chest inhibition techniques.
2. Pursed lip
Breathing Exercises-
Due
to effect of positive pressure on respiratory tract reduce narrowing of airway may produce
relief to the patient.
3. Upright positioning-
During
this position downward sifting of abdominal viscera increase efficiency or
activation of diaphragm muscle and changes the diameter of airway may increase Tidal
volume, and normalize respiratory rate improve ventilation perfusion.
4.
Expiratory exercises-
Provide
more repetition of expiratory exercise (10 R) compare to inspiratory exercise (5
R) may reduce air trapping in the lungs.
5.
Deep Breathing Exercises-
Improve
function of diaphragm and ventilation perfusion.
B.
Increase inspiratory and expiratory muscle training-
Increase
inspiratory and expiratory muscle endurance, strength and power with IMT (inspiratory
muscle training) device.
C.
CHRONIC STAGES-
1.
Facilitation secretion –Huffing/Coughing, assisted coughing active or passive techniques.
2.
Airway clearance techniques –Active cycle of breathing technique (ACBT), Autogenic
drainage (AD), Postural drainage (PD) with percussion, vibration, shaking
techniques.
3.
Facilitation ventilation patterns –Breath hold techniques, Incentive spirometer, diaphragmatic facilitation techniques can be use for better results.
Physiotherapy management in out patints phase
Exercise testing for bronchial asthma patients
Exercise testing for bronchial asthma patients
- Screening of physiological functions should be necessary before and after exercise eg. SpO2, PFT, BP Cardiopulmonary Capacity with noninvasive method.
- The mode of exercise testing it should be treadmill or Cycle ergometer with standard progressive maximal testing protocol with appropriate age group child, adult, older adult.
- To prevent exercise induced bronchoconstriction bronchodilator should be used to assess optimal cardiopulmonary capacity and vigorous intensity exercise (HR max or 40%-60%) lasting 4-6 min on treadmill or cycle ergometer.
- When Saturation of the SpO2 is decrease ≤ 80% it should be use as a termination criteria.
- To measure exertional dyspnea Borg CR 10 scale should be use and instructed to the patient for dyspnea and discomfort during the exercise testing session. 6 min walk test may be used in patients with moderate to sever persistent asthma.
Main components are used for exercise training session:
Warm-up:
Cardiorespiratory and muscular endurance activities (light-to-moderate intensity) at least 5–10 min.
Conditioning: Aerobic, resistance, neuromotor, and/ or sports
activities at least 20– 60 min/day with bouts according to individuals.
Cool-down: cardiorespiratory and muscular endurance activities at
least 5–10 min with light-to-moderate intensity.
Stretching: After the warm-up or cool down phase at least 10 min of
stretching exercises needed.
Frequency: 2-3 d/wk.
Intensity: approximately at the ventilatory anaerobic threshold or
at least 60% VO2 peak decide to progressive
exercise testing with expired gases measurement or 80% of walking speed decided
from 6 min walk test with RPE (rating of perceived exertion) 11-13 on a 6-20
scale.
Time: It shoud be at leatst 20-30 min/day.
Type: It includes aerobic activity using large muscle groups in
a rhythmic and continuous fashion eg. Walking, running, treadmill, cycle
ergometer, swimming.
Progression: After the first month if exercise prescription is well tolerated by
the individual progression should be
needed approximately 70% VO2 peak and
the frequency to 5 d/wk with each exercise session to 40 min /d.
Resistance Exercise Training
(Resistance exercise training, flexibility
training and neuromotor training should follow the same principle of exercise
testing and prescription for healthy individuals)
FITT-VP
Frequency-Each major muscle group should be trained on 2–3 d/wk.
Intensity-
- 60%–70% 1-RM (moderate-to-vigorous intensity) to
improve strength.
- >=80% 1-RM (vigorous-to-very vigorous intensity) for
experienced strength trainers to improve strength.
- 40%–50% RM (very light-to-light intensity) for older
individuals to improve strength in beginning of resistance exercise.
- 40%–50% 1-RM (very light-to-light intensity) may be
beneficial for sedentary individuals to improve strength.
- <50% 1-RM (light-to-moderate intensity) to improve
muscular endurance.
- 20%–50% 1-RM in older adults to improve power.
Time: No specific duration known for effectiveness.
Type: It should be involve each major muscle group with multi
joint or single joint exercises affecting more than one muscle group and
targeting agonist and antagonist muscle groups are recommended for all adults.
Repetitions:
· 8–12 repetitions is required to improve strength and
power in most adults.
· 10–15 repetitions is required to improve strength in
middle-aged and older individuals.
· 15–20 repetitions are recommended to improve muscular
endurance.
Sets:
· 2–4 sets are required to improve strength and power for
most adults.
· A single set is effective especially among older people.
· 2 sets are effective to increase muscular endurance.
Pattern:
· 2–3 min rest intervals between each set of repetitions
more effective.
· A rest of >=48 h between sessions for any single muscle
group is suggested.
Progression: A gradual progression of greater resistance,
repetitions per set, or increasing frequency is suggested.
Flexibility Training
FITT-VP
Frequency: It should be >=2–3d/wk.
Intensity: Stretch the large group of muscle up to feeling of
discomfort or tightness.
Time: Holding a static stretch for 10–30s is recommended for
most adults and 30–60s for older individuals but it must be changed with
stretching techniques.
Type: It may be Static flexibility (i.e., active or passive),
dynamic flexibility, ballistic flexibility, and PNF.
Volume: It should be 60 s of total stretching time for each
flexibility exercise.
Pattern:
· To produce more
effect of stretching it may require warm up with actively or passively through
light-to-moderate aerobic activity or application of externally moist heat
packs respectively.
· 2–4 times repetition is recommended.
Progression:
Unknown
Resourse:
1.Kasper, Fouci et al;Harrisons principal of internal medicine 19th edition.
2.Nicki R. Colledge,Brian R.walker, Stuart H.Raistone et al; Devidsons principles and practice of medicine. 21th edition.
3.Terry des Jardins, George G.Burtonet et al;Clinical menifestation and assessment of respiratory diseases;
7th edition.
4.Linda s., Ross Arena,Deborah Riebe et al;ACSM Guidline for Exercise testing and priscripyion 9th edition 2014.
5.Donna frowenfelter,elizabeth Dean et al;Cardiovascular and pulmonary physical therapy;5th edition 2016.
6.Robert M kacmarek, Jamesh k. stoller, Albert J Heuer;Egans fundamental of respiratory care; 11th edition.
1.Kasper, Fouci et al;Harrisons principal of internal medicine 19th edition.
2.Nicki R. Colledge,Brian R.walker, Stuart H.Raistone et al; Devidsons principles and practice of medicine. 21th edition.
3.Terry des Jardins, George G.Burtonet et al;Clinical menifestation and assessment of respiratory diseases;
7th edition.
4.Linda s., Ross Arena,Deborah Riebe et al;ACSM Guidline for Exercise testing and priscripyion 9th edition 2014.
5.Donna frowenfelter,elizabeth Dean et al;Cardiovascular and pulmonary physical therapy;5th edition 2016.
6.Robert M kacmarek, Jamesh k. stoller, Albert J Heuer;Egans fundamental of respiratory care; 11th edition.


Thank you so much sir..its really helpful..
ReplyDeleteit's very impressive blogpost. Thanks for sharing
ReplyDeleteBest Physiotherapy Clinic